Abbott India Limited (BOM: 500488)
India
· Delayed Price · Currency is INR
27,952
+641 (2.35%)
At close: Jan 17, 2025
Abbott India Revenue
Abbott India had revenue of 16.33B INR in the quarter ending September 30, 2024, with 9.27% growth. This brings the company's revenue in the last twelve months to 60.66B, up 7.58% year-over-year. In the fiscal year ending March 31, 2024, Abbott India had annual revenue of 58.49B with 9.35% growth.
Revenue (ttm)
60.66B
Revenue Growth
+7.58%
P/S Ratio
9.68
Revenue / Employee
15.90M
Employees
3,814
Market Cap
587.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
Mar 31, 2021 | 43.10B | 2.17B | 5.30% |
Mar 31, 2020 | 40.93B | 4.15B | 11.27% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |
Abbott India News
- 7 days ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 14 days ago - Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today - Business Upturn
- 6 weeks ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 7 weeks ago - Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children - Business Upturn
- 2 months ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn
- 2 months ago - Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY - Business Upturn
- 3 months ago - Pharma stocks today: Gland Pharma rises 1.53%, Aurobindo Pharma up 1.38%, while Natco Pharma falls 1.40%, and Laurus Labs down 1.41% - Business Upturn
- 3 months ago - Pharma Stocks Update: Check out how Cipla, Lupin, Abbott India, Divi’s Lab, Zydus Life, Dr Reddy’s Lab are performing today - Business Upturn